IDEX Corp. Q1 2010 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2010. IDEX Corporation is an applied solutions company operating through four segments: Fluid & Metering Technologies, Health & Science Technologies, Dispensing Equipment, and Fire & Safety/Diversified Products. The company designs and manufactures precision fluidics, pumps, and safety equipment for industrial, medical, and commercial markets.
Key Financial Metrics
| Metric (in thousands) | Q1 2010 | Q1 2009 |
|---|---|---|
| Net Sales | $355,598 | $326,613 |
| Gross Profit | $147,541 | $123,194 |
| Operating Income | $57,893 | $39,161 |
| Net Income | $36,625 | $22,605 |
| Diluted EPS | $0.45 | $0.28 |
| Operating Cash Flow | $27,131 | $17,643 |
| Cash and Equivalents | $71,388 | $63,097 |
| Total Debt | $385,707 | $400,100 |
Margins: Gross margin improved to 41.5% (from 37.7% in Q1 2009). Operating margin increased to 16.3% (from 12.0%). The effective tax rate was 33.1%.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9% year-over-year, driven by a 6% increase in organic sales and 3% favorable foreign currency translation.
- Profitability: Net income rose 62% to $36.6 million. Operating income increased 48% to $57.9 million, aided by higher volume, cost reductions from restructuring, and the absence of prior-year acquisition charges.
- Segment Performance:
- Fluid & Metering: Sales up 10% (organic +7%); Operating income up 42%.
- Health & Science: Sales up 18% (organic +17%); Operating income up 88%.
- Dispensing Equipment: Sales up 2%; Operating income up 67% due to productivity gains.
- Fire & Safety: Sales down 2% (organic -5%); Operating income slightly down.
- Debt Reduction: Total borrowings decreased by approximately $14.4 million to $385.7 million. Interest expense dropped to $3.4 million from $4.8 million.
- Restructuring: Pre-tax restructuring expenses were $1.9 million, down from $2.3 million in Q1 2009. The company expects to incur an additional $2.0–$3.0 million for the 2009 initiative by year-end.
Outlook, Risks, and Subsequent Events
- Acquisition: On April 15, 2010, IDEX acquired Seals, Ltd. for approximately $54.0 million. Seals specializes in high-performance seals and will operate within the Health & Science Technologies segment.
- Debt Strategy: The company entered into a forward-starting interest rate swap for $300.0 million to lock in rates in anticipation of issuing new debt in Q4 2010.
- Liquidity: Working capital stands at $300.9 million with a current ratio of 2.6. The company maintains a $600 million credit facility with approximately $302.5 million available.
- Risks: The company is evaluating the impact of new U.S. healthcare legislation (Patient Protection and Affordable Care Act) but does not expect a material impact. Ongoing asbestos-related litigation is covered by insurance, with no material adverse effect expected.
Investor Verification Checklist
- Verify the integration progress and revenue contribution of the newly acquired Seals, Ltd. business.
- Monitor the execution of the planned $300 million debt issuance in Q4 2010 and the associated interest rate swap.
- Track the completion of the 2009 restructuring initiative and the realization of expected cost savings.
- Assess the sustainability of the 17% organic growth in the Health & Science Technologies segment.
- Review the impact of foreign currency fluctuations on future earnings, given 47% of sales are international.